Nearly all Americans are now aware of GLP-1 medications, with many expressing interest as adoption continues to rise. A new U.S. study, "Beyond Weight Loss" from Reach3 Insights finds that 92% of ...
People are reporting hair loss months after starting GLP-1s like Ozempic and Wegovy, and doctors say it's a possible side ...
GLP-1 drugs are fueling a surge in direct-to-consumer medications. But convenience may be replacing coordination—and creating ...
Susan Cantrell, CEO of AMCP, explained in an interview with The American Journal of Managed Care® ( AJMC®) that the ...
Through the collaboration, users will be able to authorize Welldoc to access their health information through b.well's national health data network. b.well leverages a 13-step data refinery process ...
McCormick & Company (MKC) will be merging with Unilever Food (UL) in a deal valued at nearly $66 billion. McCormick chairman ...
A new study may show why Ozempic works better for some people than others.
Pharmaceutical Executive: How does the complexity of obesity impact the effectiveness of GLP-1s? Mark Bagnall: This is one of ...
GPs are invited to a free two-day virtual event next month featuring a variety of clinical topics, including NICE type 2 ...
Weight loss injections are increasingly used for pre-wedding transformations These medications carry risks when used without ...
Menopause: Dual‑sequence study shows meaningful skin quality improvements and growing patient satisfaction with both Restylane Skinboosters and Sculptra New interim results from a nine‑month clinical ...
It is almost 60 years since the original Wilson and Jungner1 criteria for evaluating population screening programmes were published, with the tenets presented having stood the test of time. Liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results